Market Research Logo

Biologics Global Market Opportunities And Strategies To 2021Including: Monoclonal Antibodies, Therapeutic Proteins, VaccinesCovering: Amgen, AbbVie, Johnson & Johnson, Bristol-Meyers Squibb, Pfizer Inc., Eli Lilly and Company, F. Hoffmann- La Roche, Merck

Biologics Global Market Opportunities And Strategies To 2021Including: Monoclonal Antibodies, Therapeutic Proteins, VaccinesCovering: Amgen, AbbVie, Johnson & Johnson, Bristol-Meyers Squibb, Pfizer Inc., Eli Lilly and Company, F. Hoffmann- La Roche, Merck & Co., GlaxoSmithKline, Sanofi

The biologics industry comprises companies manufacturing biological products that are derived from genetically modified proteins and human genes. Biologics products include a wide range of recombinant therapeutic proteins, vaccines, and monoclonal antibodies. These products are isolated from natural sources such as human, animal, and microorganisms by biotechnological methods and other cutting-edge technologies.

Reasons to Purchase

  • Outperform competitors using accurate up to date demand-side dynamics information.
  • Identify growth segments for investment.
  • Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.
  • Create regional and country strategies on the basis of local data and analysis.
  • Stay abreast of the latest customer and market research findings
  • Benchmark performance against key competitors.
  • Develop strategies based on likely future developments.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Gain a global perspective on the development of the market.
  • Report will be updated with the latest data and delivered to you within 10 working days of order.
Description

Where is the largest and fastest growing market for biologics? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Biologics market report from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • A comparison of the biologics market with macro-economic factors and industry metrics is also covered in the report.
  • PESTLE Analysis covers the political, economic, social, technological, legal and environmental factors affecting the biologics market.
  • Market segmentations break down market into sub markets, including Monoclonal Antibodies, Therapeutic Proteins, Vaccines
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The report also covers key mergers and acquisitions in the biologics market. Key financial deals which have shaped the market in recent years are identified.
Scope

Markets covered: Monoclonal Antibodies, Therapeutic Proteins, Vaccines

Companies mentioned: Amgen, AbbVie, Johnson & Johnson, Bristol-Meyers Squibb, Pfizer Inc., Eli Lilly and Company, F. Hoffmann- La Roche, Merck & Co., GlaxoSmithKline, Sanofi

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, population, GDP

Data segmentations: Country historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.


1. Executive Summary
2. Biologics Market Characteristics
2.1. Market Overview
2.2. Market Segmentation
2.3. Market Value Chain
3. Biologics Market Size And Growth
3.1. Biologics Historic Market Growth
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Biologics Market Forecast Growth
3.2.1. Drivers Of The Market
3.2.2. Restraints On The Market
4. PESTLE Analysis
4.1. Political
4.2. Economic
4.3. Social
4.4. Technological
4.5. Legal
4.6. Environmental
5. Biologics Market Segmentation
5.1. Global Biologics Market, 2017, Split By Segments, $ Billion
5.1.1. Monoclonal Antibodies (mAbs)
5.1.2. Therapeutic Proteins
5.1.3. Vaccines
5.2. Global Biologics Market, Historic and Forecast Growth Rates, Split By Segments, 2013-2021
6. Global Biologics Market Trends And Strategies
7. Global Biologics Market Compared With Similar Markets, 2017
7.1. Healthcare Market Segmentation, By Region, 2017
7.2. Healthcare Market Segmentation, By Country, 2017
8. Global Biologics Market Segment Details
8.1. Monoclonal Antibodies (mAbs)
8.1.1. Monoclonal Antibodies Market Characteristics
8.1.2. Global Monoclonal Antibodies Market, 2017, By Source
8.1.3. Global Monoclonal Antibodies Market, 2017, By Therapeutic Area
8.1.4. Monoclonal Antibodies Market Trends And Strategies
8.2. Therapeutic Proteins
8.2.1. Therapeutic Proteins Market Characteristics
8.2.2. Global Therapeutic Proteins Market, 2017, By Type
8.2.3. Global Therapeutic Proteins Market, 2017, By Therapeutic Area
8.2.4. Therapeutic Proteins Market Trends And Strategies
8.3. Vaccines
8.3.1. Vaccines Market Characteristics
8.3.2. Global Vaccines Market, 2017, By End User
8.3.3. Global Vaccines Market, 2017, By Segment
8.3.4. Vaccines Market Trends And Strategies
9. Biologics Market Geography Regional and Country Analysis
9.1. Biologics Market, 2017, By Region
9.2. Biologics Market, Historic And Forecast Growth Rates, Split By Region, 2013-2021
9.3. Biologics Market, Split By Country, 2017
9.4. Biologics Market, Historic And Forecast Growth Rates, Split By Country, 2013-2021
10. Global Biologics Market Comparison With Macro Economic Factors
10.1. Biologics Market Size, Percentage Of GDP, Global
10.2. Per Capita Average Biologics Expenditure, Global
10.3. Biologics Market Size, Percentage of GDP, By Country
10.4. Per Capita Average Biologics Expenditure, By Country
11. Biologics Market Comparison With Industry Metrics
11.1. Biologics & Biosimilars Sales Proportion By Country (Value), 2017, By Country
11.2. Global Biologics Under Development, 2017
11.3. New Biologics Approvals, 2017
11.4. Number Of General Practitioners 2016, By Country
11.5. Average Revenue Per General Practitioners 2016, By Country
12. Biologics Market Regional And Country Analysis
12.1. Asia-Pacific Biologics Market
12.1.1. Asia-Pacific Biologics Market Overview
12.1.2. Asia Pacific Biologics Market
12.1.3. Asia-Pacific Biologics Historic Market, 2013-2017
12.1.4. Asia-Pacific Biologics Forecast Market, 2017-2021
12.1.5. Asia-Pacific Biologics Market, 2017, By Segment
12.2. China Biologics Market Overview
12.2.1. China Biologics Market
12.2.2. China Biologics Historic Market, 2013-2017
12.2.3. China Biologics Forecast Market, 2017-2021
12.2.4. China Biologics Market, 2017, By Segment
12.3. India Biologics Market Overview
12.3.1. India Biologics Market
12.3.2. India Biologics Historic Market, 2013-2017
12.3.3. India Biologics Forecast Market, 2017-2021
12.3.4. India Biologics Market, 2017, By Segment
12.4. Japan Biologics Market Overview
12.4.1. Japan Biologics Market
12.4.2. Japan Biologics Historic Market, 2013-2017
12.4.3. Japan Biologics Forecast Market, 2017-2021
12.4.4. Japan Biologics Market, 2017, By Segment
12.5. Australia Biologics Market Overview
12.5.1. Australia Biologics Market
12.5.2. Australia Biologics Historic Market, 2013-2017
12.5.3. Australia Biologics Forecast Market, 2017-2021
12.5.4. Australia Biologics Market, 2017, By Segment
13.1. Western Europe Biologics Market
13.1.1. Western Europe Biologics Market Overview
13.1.2. Western Europe Biologics Market
13.1.3. Western Europe Biologics Historic Market, 2013-2017
13.1.4. Western Europe Biologics Forecast Market, 2017-2021
13.1.5. Western Europe Biologics Market, 2017, By Segment
13.2. UK Biologics Market Overview
13.2.1. UK Biologics Market
13.2.2. UK Biologics Historic Market, 2013-2017
13.2.3. UK Biologics Forecast Market, 2017-2021
13.2.4. UK Biologics Market, 2017, By Segment
13.3. Germany Biologics Market Overview
13.3.1. Germany Biologics Market
13.3.2. Germany Biologics Historic Market, 2013-2017
13.3.3. Germany Biologics Forecast Market, 2017-2021
13.3.4. Germany Biologics Market, 2017, By Segment
13.4. France Biologics Market Overview
13.4.1. France Biologics Market
13.4.2. France Biologics Historic Market, 2013-2017
13.4.3. France Biologics Forecast Market, 2017-2021
13.4.4. France Biologics Market, 2017, By Segment
13.5. Italy Biologics Market Overview
13.5.1. Italy Biologics Market
13.5.2. Italy Biologics Historic Market, 2013-2017
13.5.3. Italy Biologics Forecast Market, 2017-2021
13.5.4. Italy Biologics Market, 2017, By Segment
13.6. Spain Biologics Market Overview
13.6.1. Spain Biologics Market
13.6.2. Spain Biologics Historic Market, 2013-2017
13.6.3. Spain Biologics Forecast Market, 2017-2021
13.6.4. Spain Biologics Market, 2017, By Segment
14.1. Eastern Europe Biologics Market
14.1.1. Eastern Europe Biologics Market Overview
14.1.2. Eastern Europe Biologics Market
14.1.3. Eastern Europe Biologics Historic Market, 2013-2017
14.1.4. Eastern Europe Biologics Forecast Market, 2017-2021
14.1.5. Eastern Europe Biologics Market, 2017, By Segment
14.2. Russia Biologics Market Overview
14.2.1. Russia Biologics Market
14.2.2. Russia Biologics Historic Market, 2013-2017
14.2.3. Russia Biologics Forecast Market, 2017-2021
14.2.4. Russia Biologics Market, 2017, By Segment
15.1. North America Biologics Market
15.1.1. North America Biologics Market Overview
15.1.2. North America Biologics Market
15.1.3. North America Biologics Historic Market, 2013-2017
15.1.4. North America Biologics Forecast Market, 2017-2021
15.1.5. North America Biologics Market, 2017, By Segment
15.2. USA Biologics Market Overview
15.2.1. USA Biologics Market
15.2.2. USA Biologics Historic Market, 2013-2017
15.2.3. USA Biologics Forecast Market, 2017-2021
15.2.4. USA Biologics Market, 2017, By Segment
16.1. South America Biologics Market
16.1.1. South America Biologics Market Overview
16.1.2. South America Biologics Market
16.1.3. South America Biologics Historic Market, 2013-2017
16.1.4. South America Biologics Forecast Market, 2017-2021
16.1.5. South America Biologics Market, 2017, By Segment
16.2. Brazil Biologics Market Overview
16.2.1. Brazil Biologics Market
16.2.2. Brazil Biologics Historic Market, 2013-2017
16.2.3. Brazil Biologics Forecast Market, 2017-2021
16.2.4. Brazil Biologics Market, 2017, By Segment
17.1. Middle East Biologics Market
17.1.1. Middle East Biologics Market Overview
17.1.2. Middle East Biologics Market
17.1.3. Middle East Biologics Historic Market, 2013-2017
17.1.4. Middle East Biologics Forecast Market, 2017-2021
17.1.5. Middle East Biologics Market, 2017, By Segment
18.1. Africa Biologics Market
18.1.1. Africa Biologics Market Overview
18.1.2. Africa Biologics Market
18.1.3. Africa Biologics Historic Market, 2013-2017
18.1.4. Africa Biologics Forecast Market, 2017-2021
18.1.5. Africa Biologics Market, 2017, By Segment
19. Biologics Market Competitive Landscape
19.1. Johnson & Johnson (J&J)
19.2. F.Hoffmann-La Roche
19.3. Bristol-Myers Squibb
19.4. GlaxoSmithKline
19.5. AbbVie
19.6. Amgen
19.7. Sanofi
19.8. Eli Lilly and Company
19.9. Merck & Co.
19.1. Pfizer Inc.
20. Biologics Market Key Mergers And Acquisitions
21. Appendix

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report